Rôle de la TEP dans le lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

6 décembre 2024

Prise en charge de la rechute lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

PTCL-TFH

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Physiopathologie lymphome NK/T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

1ere ligne lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Lymphome NK/T nasal

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Autogreffe et allogreffe lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Diagnostic lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Biologie moléculaire lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Biologie lymphome T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Anatomopathologie lymphomes T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

ALCL et EATL

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Allogreffe et transfusions

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

29 juin 2024

Conditionnements des allogreffes : pourquoi et comment ?

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

GVH aiguë

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

GVH chronique

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Allogreffe des sujets âgés

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Complications et effets tardifs de l’allogreffe

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Quel donneur ? Quel greffon ?

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Traitement antitumoral post allogreffe

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Leucémie myélomonocytaire chronique

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Evolution clonale de l’hématopoïèse normale et leucémique

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Physiopathologie des SMD

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Diagnostic et choix de traitement des SMD de haut risque

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

SMD : Biologie moléculaire

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

12 mai 2024

SMD : Manifestations extra-hématologiques dysimmunitaires

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

SMD : Allogreffe

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

SMD : Cytologie et classification

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

Immunothérapie dans la leucémie aigue lymphoblastique

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre

23 avril 2024

Physiopathologie de la leucémie aigue lymphoblastique T

You need to be logged in to view this content. Veuillez Log In. Not a Member? Nous Rejoindre